|
Children's Oncology Group Statistics and Data Center
|
5U10CA098413-05
|
$5,859,839
|
ANDERSON, JAMES
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
Z01 SC 010378
|
$636,008
|
Aplan, Peter
|
CCR (NCI)
|
|
Mechanisms of Chromosomal Translocation
|
Z01 SC 010379
|
$313,257
|
Aplan, Peter
|
CCR (NCI)
|
|
GENETIC PREDICTORS OF LEUKEMIA THERAPY RESPONSE
|
5R01CA108862-03
|
$256,930
|
Aplenc, Richard
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Significance of Bone Marrow Karyotypes in Patients with Inherited Bone Marrow Fai
|
Z01 BC 010692
|
$68,001
|
Arthur, Diane
|
CCR (NCI)
|
|
Metabolic Syndrome Following Transplant for Leukemia
|
5R01CA112530-02
|
$420,764
|
BAKER, KEVIN
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Drug Development and Clinical Pharmacology of Anticancer Drugs for Childhood Canc
|
Z01 SC 006880
|
$1,453,500
|
Balis, Frank
|
CCR (NCI)
|
|
Molecular Determinants of Methotrexate in ALL
|
5R01CA098152-05
|
$297,317
|
BARREDO, JULIO
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Regional Oncology Research Center
|
3P30CA006973-45S1
|
$231,549
|
BAYLIN, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-45S2
|
$126,362
|
BAYLIN, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
5P30CA006973-45
|
$7,564,613
|
BAYLIN, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA042014-20
|
$693,487
|
Beckerle, Mary
|
UNIVERSITY OF UTAH
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S1
|
$124,531
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S3
|
$137,869
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S4
|
$232,326
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S5
|
$250,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-43
|
$11,526,509
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Pediaric Oncology Research Training Program
|
2T32CA009351-29
|
$237,038
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Ethnic Differences in Survival after Childhood ALL
|
5R01CA096670-04
|
$485,753
|
BHATIA, SMITA
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Genetic Consequences of Therapies for Cancer
|
5R01CA104666-03
|
$600,831
|
BOICE, JOHN
|
VANDERBILT UNIVERSITY
|
|
Deficits in Facial Expression Recognition in Childhood Cancer Survivors
|
1R03CA128472-01
|
$92,338
|
BONNER, MELANIE
|
DUKE UNIVERSITY
|
|
Minimal Residual Disease in Pediatric ALL in Relation to Other Prognostic Factors
|
5R01CA086011-07
|
$542,666
|
BOROWITZ, MICHAEL
|
JOHNS HOPKINS UNIVERSITY
|
|
ROLE OF mTOR INHIBITORS AND IL7 IN LYMPHOID MALIGNANCIES
|
5K08CA104882-04
|
$138,672
|
BROWN, VALERIE
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Developing FLT3-Targeted Therapy for Pediatric Leukemia
|
5K23CA111728-02
|
$140,130
|
BROWN, PATRICK
|
JOHNS HOPKINS UNIVERSITY
|
|
MHC Genetic Variation, Exposure to Infections and Risk of Childhood Leukemia
|
1R03CA125823-01A1
|
$60,215
|
Buffler, Patricia
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
Childhood Leukemia International Consortium (CLIC)
|
1R03CA132172-01
|
$62,413
|
Buffler, Patricia
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
Cell Therapy of Refractory Leukemia
|
5R01CA113482-02
|
$281,365
|
CAMPANA, DARIO
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Clinical Significance of Residual Myeloid Leukemia
|
5R01CA115422-02
|
$255,555
|
CAMPANA, DARIO
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Mechanisms of T Cell Tumorigenesis
|
5R01CA100875-04
|
$238,942
|
Chen, Jianzhu
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Pathology and Biology of Leukemia Oncogenes
|
5R01CA055029-17
|
$373,311
|
CLEARY, MICHAEL
|
STANFORD UNIVERSITY
|
|
Role of PBX Proteins in Hematopoiesis and Growth Control
|
5R01CA090735-07
|
$299,598
|
CLEARY, MICHAEL
|
STANFORD UNIVERSITY
|
|
Mechanisms of Leukemogenesis in Down Syndrome
|
2R01CA101774-05
|
$305,707
|
CRISPINO, JOHN
|
NORTHWESTERN UNIVERSITY
|
|
Molecular genetics of MLL-associated leukemia
|
3P01CA105049-03S1
|
$127,761
|
DIAZ, MANUEL
|
LOYOLA UNIVERSITY CHICAGO
|
|
Molecular genetics of MLL-associated leukemia
|
5P01CA105049-03
|
$1,166,954
|
DIAZ, MANUEL
|
LOYOLA UNIVERSITY CHICAGO
|
|
Promoting Treatment Adherence in Adolescent Leukemia
|
1R01CA119162-01A1
|
$701,307
|
DROTAR, DENNIS
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
Cancer Center Support Grant
|
3P30CA091842-07S1
|
$85,134
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA091842-07S2
|
$238,995
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA091842-07
|
$3,978,214
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
North American Juvenile Myelomonocytic Leukemia Project
|
5R01CA095621-05
|
$317,003
|
EMANUEL, PETER
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
PHARMACODYNAMICS OF ANTILEUKEMIC AGENTS IN CHILDREN
|
5R01CA078224-10
|
$480,447
|
EVANS, WILLIAM
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
PHARMACOGENOMICS OF CHILDHOOD LEUKEMIA (ALL)
|
5R37CA036401-24
|
$574,893
|
EVANS, WILLIAM
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
ANTINEOPLASTIC v LEUKEMOGENIC EPIPODOPHYLLOTOXIN EFFECTS
|
5R01CA077683-08
|
$266,610
|
Felix, Carolyn
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Mechanisms of T-Cell Leukemogenesis Induced by Notch1
|
1R01CA120196-01A1
|
$305,900
|
FERRANDO, ADOLFO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Genotoxicity & Emergence of Genome Instability in Humans
|
5R01CA094013-05
|
$319,620
|
FINETTE, BARRY
|
UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
|
|
Quality Assurance Review Center
|
2U10CA029511-28
|
$1,871,106
|
FITZGERALD, THOMAS
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
CANCER CENTER SUPPORT GRANT (CCSG)
|
3P30CA022435-22S2
|
$1,304,917
|
FOGARTY, JOHN
|
UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
|
|
Postgraduate Training in Pediatric Oncology
|
5T32CA082086-08
|
$302,117
|
GARCEA, ROBERT
|
UNIVERSITY OF COLORADO DENVER/HSC AURORA
|
|
Variation in Ara-C Pathway Genes and Treatment Outcomes in AML
|
1R21CA119142-01A1
|
$164,365
|
GOYAL, RAKESH
|
CHILDREN'S HOSP PITTSBURGH/UPMC HLTH SYS
|
|
Genetic and Pharmacogenetic Modifiers of Cancer Risk and Intervention Outcomes
|
Z01 CP010142
|
$327,710
|
Greene
|
DCEG (NCI)
|
|
Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes
|
Z01 CP010144
|
$2,033,740
|
Greene
|
DCEG (NCI)
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|